Novavax's Covid─19─influenza combination and stand─alone influenza vaccine candidates showed robust immune responses and ...
Novavax, Inc. announced results of the initial cohort of its Covid-19-Influenza Combination (CIC) and stand-alone trivalent hemagglutinin nanoparticle seasonal influenza (tNIV) phase 3 trial that showed both the CIC and flu vaccine candidates induced …